Drug intelligence / Profile preview

Zhangyanming Pian

Development stage
Unknown
Lead developer
Guangzhou Baiyunshan Zhongyi Pharmaceutical
Administration
Oral
01

Overview

Zhangyanming Pian is a traditional Chinese medicine (TCM) formulated as tablets, primarily indicated for the treatment of early and middle-stage senile cataracts. It is classified as a non-prescription Chinese patent medicine. The drug's therapeutic actions, rooted in TCM principles, include tonifying the liver and kidney, clearing liver and brightening eyes, dispelling nebula, promoting blood circulation, removing blood stasis, moistening intestines, and promoting bowel movement. Its complex composition consists of numerous herbal ingredients, which collectively aim to alleviate symptoms associated with liver and kidney deficiency, such as dry eyes, monocular diplopia, and blurred vision. Recent research also explores its potential in conditions like diabetic retinopathy, dry eye syndrome, and retinitis pigmentosa, suggesting broader ophthalmic applications beyond its traditional use.

Brand names
Zhongyi Zhangyanming Pian
Other names
障眼明片Zhang Yan Ming Pian
02

Targets

IL1B (Interleukin-1 beta)BCL-2 (BCL-2 family)MMP9 (Matrix metalloproteinase-9)HIF1A (Hypoxia-inducible factor 1-alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)EGFR T790M (Epidermal growth factor receptor T790M mutant)IL-6 (Interleukin 6)CASP3 (Caspase-3)

Beyond the preview

Go deeper on Zhangyanming Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhangyanming Pian.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call